Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
December 18, 2025
Biotechnology
-
-
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
December 17, 2025
-
Iterum Therapeutics Provides Business Update
December 17, 2025
-
Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update
December 12, 2025
-
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition
December 5, 2025
-
Protara Announces Pricing of $75 Million Public Offering
December 4, 2025
-
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
December 1, 2025
-
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
November 26, 2025
-
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty
November 26, 2025
-
Moleculin Announces Reverse Stock Split
November 26, 2025
-
Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement
November 26, 2025
-
Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules
November 24, 2025
-
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
November 24, 2025
-
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
November 17, 2025
-
Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
November 17, 2025
-
CytoDyn Secures $30 Million Commitment from Yorkville Advisors
November 3, 2025